drugset / Trial / NCT02604914
A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
An Open-Label Study in Healthy Male and Female Subjects to Identify the Concentration that Provides Optimal Bioavailability of Levodopa Infused Subcutaneously via a Pump System; and to Compare the Bioavailability of Levodopa/Carbidopa Solution to that of Levodopa/Carbidopa Intestinal Gel (LCIG), Infused via a Naso-Jejunal Tube
Timeline
- Start
- 2015-05-29
- Primary completion
- 2016-06-30
- Completion
- 2016-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | LCIG | Unknown | — | Other |
| Subject | ND0612 | Unknown | 0.24 ml | Subcutaneous |
| Subject | ND0612 | Unknown | 0.64 ml | Subcutaneous |